Jupiter Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-57,100
Closed -$2.47M 209
2015
Q3
$2.47M Sell
57,100
-140,200
-71% -$5.92M 0.1% 176
2015
Q2
$8.34M Buy
+197,300
New +$8.32M 0.29% 80
2015
Q1
Sell
-218,600
Closed -$8.42M 87
2014
Q4
$7.36M Sell
218,600
-12,000
-5% -$424K 0.24% 105
2014
Q3
$8.08M Buy
230,600
+26,500
+13% +$908K 0.27% 92
2014
Q2
$6.71M Sell
204,100
-24,400
-11% -$835K 0.21% 113
2014
Q1
$8.42M Sell
228,500
-6,000
-3% -$220K 0.27% 111
2013
Q4
$9M Sell
234,500
-29,500
-11% -$931K 0.35% 98
2013
Q3
$7.23M Sell
264,000
-103,000
-28% -$2.44M 0.32% 100
2013
Q2
$7.71M Buy
+367,000
New +$7.17M 0.34% 98

Other funds holding WX

Jupiter Asset Management's WX Position: Q4 2015 in Review

Jupiter Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 57,100 shares — an estimated $2.47M sold.

Jupiter Asset Management first reported a position in WX in Q2 2013 and held it in 9 quarters. The position peaked at $9M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Jupiter Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Jupiter Asset Management sold 57,100 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.47M.
  • Jupiter Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 9 quarters.
  • Jupiter Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $9M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Jupiter Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.